3 terminated, 2 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Completed 2 |
Follow GLYX-13 peptide: new trials by email Literature Review of GLYX-13 peptide trials Research Report on GLYX-13 peptide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder Rapastinel, Placebo - Depressive Disorder, Major | Phase 2 | Terminated | Naurex, Inc, an affiliate of Allergan plc | 138 | 2017-12-15 | 2020-08-14 |
| Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder Rapastinel (formerly GLYX-13) - Obsessive-Compulsive Disorder (OCD) | Phase 2 | Completed | New York State Psychiatric Institute | 7 | 2014-10-01 | 2017-07-18 |
| Open Label Extension for GLYX13-C-202, NCT01684163 Rapastinel (225 mg/450 mg IV administration) - Major Depressive Disorder | Phase 2 | Terminated | Naurex, Inc, an affiliate of Allergan plc | 61 | 2014-09-08 | 2019-11-27 |
| Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness GLYX-13, Placebo - Psychiatric Illness, Healthy | Phase 2 | Terminated | Northwestern University | 44 | 2013-05-01 | 2023-04-20 |
| Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression GLYX-13 - Major Depressive Disorder | Phase 2 | Completed | Naurex, Inc, an affiliate of Allergan plc | 115 | 2011-05-01 | 2012-09-12 |
Depressive Disorder, Major (3) · Depression (1) · Mental Disorders (1) · Obsessive-Compulsive Disorder (1) · Psychotic Disorders (1) · Schizophrenia (1)
Naurex, Inc, an affiliate of Allergan plc (3) · New York State Psychiatric Institute (1) · Northwestern University (1)
United States (5)
Jenna Hoogerheyde (2) · Benji Kurian, MD (1) · Carolyn I Rodriguez, MD, PhD (1) · David Greuner, MD (1) · David Krefetz, DO (1) · James L Reilly, PhD (1) · Matthew Macaluso, MD (1) · Michael Lesem, MD (1) · Paul Gross, MD (1) · Raymond Manning, MD (1) · Ronald M Burch, MD, PhD (1) · Stephen Murray, MD PhD (1) · Surinder Randhawa, MD (1) · Vishaal Mehra, MD (1)